Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115565) titled 'The Impact of Primidone Treatment on Fluid Metabolomics in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Study' on Dec. 29, 2025.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Yichang Central People's Hospital
Condition:
amyotrophic lateral sclerosis (ALS)
Intervention:
ALS patient group:none
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2025-12-31
Target Sample Size: ALS patient group:142;Control group:70;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=30...